Brendan M.

Brendan M.'s work experience begins in 1994 as a Manufacturing Engineer at Packard BioScience Company until 1998. Brendan then moved on to Agencourt Bioscience, where they served as the VP of Operations and Co-Founder from 2000 to 2006. During their time at Agencourt, they played a significant role in developing DNA sequencing services and products. Brendan then co-founded Agencourt Personal Genomics in 2006, where they acted as Co-Founder and Board of Directors. This venture successfully developed the SOLiD DNA sequencer and was later sold to Applied Biosystems. In 2010, they became the President and Co-founder of Courtagen LifeScience until 2017. After that, Brendan joined Avon Old Farms School as the Former Co-Vice Chairman and Treasurer from 2011 to 2020. Additionally, they became an investor for Boston Harbor Angels Inc. from 2011 to 2019. In 2016, Brendan took on the role of CEO at CannMed Events and continued their journey as Chief Executive Officer and Board Member at Medicinal Genomics in 2017.

Brendan M. completed an MBA in Entrepreneurship/Entrepreneurial Studies/Operations Research from Rensselaer Polytechnic Institute from 1998 to 2000. Prior to that, they earned a Bachelor of Science degree in Management Sciences and Quantitative Methods from Muhlenberg College, where they attended from 1989 to 1993. Before attending college, Brendan M. attended Avon Old Farm School from 1986 to 1989, but no degree or field of study information is available for this institution.